AI assistant
Sending…
Syndax Pharmaceuticals Inc — Director's Dealing 2021
Oct 6, 2021
31977_dirs_2021-10-06_d13e48db-1c02-4055-8906-b31297076b1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-10-05
Reporting Person: Podlesak Dennis (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-05 | Common Stock | J | 463.00 | $0.00 | Acquired | 43763.00 | Direct |
Footnotes
F1: Represents shares of Common Stock of the Issuer received from One Palmer Square Associates VIII, L.L.C. through a pro-rata distribution for no consideration.
More from Syndax Pharmaceuticals Inc
Proxy Solicitation & Information Statement
2026
Jun 4
Capital/Financing Update
2026
Jun 4
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6